Century Bancorp is a bank holding company. Through its subsidiary, Century Bank and Trust Company, the company provides services to commercial enterprises, state and local governments and agencies, non-profit organizations and individuals. The company also provides securities brokerage services through a program called Investment Services at Century Bank, which is supported by LPL Financial, a third party securities brokerage business. The company grants single-family and multi-family residential loans, commercial and commercial real estate loans, municipal loans, and a variety of consumer loans. In addition, the company provides savings accounts, NOW accounts, demand deposits, time deposits and money market accounts.

CytomX Therapeutics is clinical-stage, oncology-focused biopharmaceutical company with a class of investigational antibody therapeutics based on its Probody? technology platform the treatment of cancer. The company uses its platform to create proprietary cancer immunotherapies against clinically-validated targets. The company's two programs, CX-072, a wholly owned PD-L1-targeting Probody therapeutic and CX-2009, wholly owned CD166-targeting Probody drug conjugate. Both CX-072 and CX-2009 are part of PROCLAIM (Probody Clinical Assessment in Man), an international umbrella clinical trial program that provides clinical trial sites with access to the company's novel therapies under one central protocol.

Homology Medicines is a genetic medicines company. The company's proprietary platform is designed to utilize its human hematopoietic stem-cell derived adeno-associated virus vectors (AAVHSCs) to deliver single administration genetic medicines in vivo either through a gene therapy or nuclease-free gene editing modality across a range of genetic disorders. The properties of the company's proprietary suite of 15 AAVHSCs enable it to focus on a method of gene editing called gene correction, either through the replacement of an entire diseased gene in the genome with a whole functional copy or the repair of individual mutated nucleotides, nucleotides.

Liquidity Services is engaged in operating a network of e-commerce marketplaces that enable buyers and sellers to transact in an automated environment. The company's reportable segments are: Retail Supply Chain Group, which consists of marketplaces that enable corporations to sell surplus and salvage consumer goods and retail capital assets; Capital Assets Group, which provides solutions to sellers and it consists of marketplaces that enable commercial businesses to sell surplus, salvage, and scrap assets; GovDeals, which provides self-directed service solutions; and Machinio, which operates an online platform for listing used equipment for sale in the construction, machine tool, among others.

Mirum Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. The company's pipeline consists of two clinical-stage product candidates, maralixibat and volixibat, with mechanisms of action that have potential utility across a wide range of orphan liver diseases.

TRACON Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of targeted therapeutics for cancer and wet age-related macular degeneration. The company is developing its primary product candidate, TRC105 (carotuximab), an endoglin antibody, for the treatment of multiple solid tumor types in combination with inhibitors of the vascular endothelial growth factor pathway, or in combination with inhibitors of the programmed cell death protein 1 pathway. The company's second clinical stage product oncology candidate is TRC102, a small molecule being developed for the treatment of lung cancer and mesothelioma.

United Insurance Holdings is a holding company. Through its subsidiaries, the company is engaged in the residential personal and commercial property and casualty insurance business in the United States. The company's insurance subsidiaries provide personal residential and commercial property and casualty insurance products that protect its policyholders against losses due to damages to structures and their contents. Some of the company's insurance subsidiaries sell policies that protect against liability for accidents as well as property damage. The company's non-insurance subsidiaries support its insurance and investment operations. The company writes in Florida, Connecticut, Georgia, Hawaii, Louisiana, and other various states.